NeoGenomics Launches New Sequencing Assay for Rapid Genetic Profiling of AML
The next-generation sequencing assay delivers rapid and comprehensive genetic profiling for AML patients, guiding precise treatment decisions.
Read MorePosted by Andy Lundin | Oct 8, 2024 | Leukemia, Sequencing Systems |
The next-generation sequencing assay delivers rapid and comprehensive genetic profiling for AML patients, guiding precise treatment decisions.
Read MorePosted by Andy Lundin | Oct 8, 2024 | Molecular Diagnostics |
Breakthrough Genomics is launching a new version of its fully-automated genome reader aimed at speeding up rare disease diagnosis.
Read MorePosted by Andy Lundin | Oct 7, 2024 | Disease States |
The Gazelle Hb Variant Test offers a faster, affordable alternative to traditional lab tests for sickle cell disease and beta thalassemia.
Read MorePosted by Andy Lundin | Oct 2, 2024 | Dementias & Alzheimer’s |
Revvity’s APOE assay allows for precise APOE genotyping to assess patient risks before starting anti-amyloid therapy for Alzheimer’s disease.
Read MorePosted by Andy Lundin | Oct 1, 2024 | Molecular Diagnostics |
Researchers developed AI-powered PCR tech that improves DNA profiling, offering more reliable results for medical applications and more.
Read More